Acreage Pharms Ltd. is a licensed producer under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). We have a team of dedicated, professional staff committed to producing cannabis for the medical market. We are also proud to be a part of Canada’s progressive movement towards legalized cannabis. Our commitment to lead and represent this burgeoning industry with honesty and transparency is at the core of who we are.
Due to new Canadian regulations governing cannabis marketing (“The Cannabis Act”), we will no longer be able to offer discounts on cannabis as part of the Lift & Co. rewards program. As a result, existing rewards members have until 11:59 pm PST, October 16, 2018 to unlock and redeem their points for medical cannabis discounts. As of October 17, all unredeemed points will be converted to the new Lift Rewards program at their original value. For more information please visit New Lift & Co. Rewards Program.
We take no shortcuts on supplying consistent, tested cannabis products without compromise for our medical clients.
We hand-trim and hang-dry our cannabis under controlled conditions to maximize customer satisfaction.
Our location in the foothills of the Alberta Rocky Mountains provides excellent conditions with low humidity and clean water and fresh air.
Our growing facilities are purpose-built to provide the conditions needed for consistent, reliable products.
Our fellow Canadians and clients are extremely important to our team and we are committed to the continual improvement of our processes, to best serve this growing market.
Large amounts of surrounding land provide the capability to construct facilities to meet the demand that medical and legal adult recreational cannabis use will create.
Our Phase II 32,000 sq. ft. expansion was recently completed. The eleven large growing and plant research rooms in Phase II will increase our capacity to produce more strains for our clients.
We also recently completed plans to construct Phase III, an additional 80,000 sq. ft. of production space containing 36 ultra-modern environmentally-controlled rooms. Phase III will further expand our production and research capacity, including specialized breeding programs to produce targeted cannabinoid profiles to better serve our clients. Estimated completion date is late summer of 2018.
Acreage Pharms will continue to expand on the 280 acres of available land to provide even more products to the Canadian market.